Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Applications to water transport systems: general discussion.

Faraday discussions·2018

Same author

The modelling and enhancement of water hydrodynamics: general discussion.

Faraday discussions·2018

Same author

Corn cob silica as an antibacterial support for silver nanoparticles: efficacy on Escherichia coli and Listeria monocytogenes.

Environmental monitoring and assessment·2018

Same author

Proteome data of

Data in brief·2018

Same author

PoreDesigner for tuning solute selectivity in a robust and highly permeable outer membrane pore.

Nature communications·2018

Same author

'We pledge to improve the health of our entire community': Improving health worker motivation and performance in Bihar, India through teamwork, recognition, and non-financial incentives.

PloS one·2018

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Persistent pneumonia: Underlying cause and outcome.

Manish Kumar¹, Niranjan Biswal, V Bhuvaneswari

¹Dept of Pediatrics, JIPMER, Pondicherry, India.

Indian Journal of Pediatrics

|November 27, 2009

Summary

Persistent pneumonia in children is often caused by ongoing infections, aspiration, and weakened immune systems. Identifying these underlying causes is crucial for effective treatment and improved child health outcomes.

More Related Videos

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Related Experiment Videos

Last Updated: Jun 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Area of Science:

Pediatrics
Infectious Diseases
Pulmonology

Background:

Persistent pneumonia presents a significant clinical challenge in pediatric care.
Identifying the etiology of prolonged pneumonia is essential for targeted management.

Purpose of the Study:

To determine the underlying causes and contributing factors of persistent pneumonia in pediatric patients.
To investigate the diverse etiological spectrum of persistent pneumonia.

Main Methods:

A comprehensive investigation of 41 pediatric cases with persistent pneumonia.
Utilized biochemical, microbiological, histopathological, immunological, and radiological assessments.

Main Results:

Identified pulmonary tuberculosis (8 cases) and Gram-negative bacterial infections (12 cases) as common infectious causes.
Aspiration due to gastroesophageal reflux or oil instillation (12 cases) and HIV-related immunodeficiency (3 cases) were also significant factors.
Congenital lung malformations (2 cases), cardiac disorders (2 cases), and foreign body aspiration (1 case) were less frequent causes.

Conclusions:

Persistent infection emerged as the most frequent underlying cause of persistent pneumonia.
Aspiration and acquired immunodeficiency were identified as the next most common etiological categories.
The study highlights the multifactorial nature of persistent pneumonia in children, necessitating a broad diagnostic approach.